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The quality of the liposome formulations differs based on the features of the compositions. 
Several investigation methods help with their results to make the right decision to achieve an 
optimised preparation. During these sets of experiments to prepare liposomes via the thin-film 
hydration technique, dynamic light scattering (DLS) and zeta potential measurements, 
thermogravimetric analysis (TGA), differential scanning calorimetry (DSC) investigations, and 
Fourier-transformed infrared (FT-IR) studies were used to select the more optimal 
compositions. The formulations differed in the phospholipid-cholesterol ratio, the type of the 




The investigation of nanocarrier systems, such as the liposomes, is one of the core points of 
pharmaceutical research and development fields [1]. Liposomes are described as artificially 
prepared vesicles composed of one or more concentric lipid bilayers that are enclosing one or 
more aqueous compartments by the European Medicine Agency [2]. Due to their bilayer 
structure, liposomes provide a sufficient opportunity for targeted drug delivery in case of both 
hydrophobic and hydrophilic compounds over the body. As the number of information and 
novelties increases, the options of developments raise as well to get a high-quality product.  
The goal of this study was to find the optimal phospholipid-cholesterol ratio, solvent, hydration 
media and cryoprotectant for liposomal formulations made from different types of PEGylated 
phospholipids (DPPE-PEG2000, DSPE-PEG3000). 
 
Experimental 
The liposomes were prepared via the thin-film hydration method [3] using different 
combinations of phosphatidylcholine, cholesterol, and PEGylated phospholipids. The particle 
size and size distribution values were determined via dynamic light scattering (DLS) technique 
and the zeta potentials of the vesicle surfaces measured with a zetasizer. Additionally, 
thermogravimetric analyses (TGA) and differential scanning calorimetry (DSC) investigations 
were done. The interactions between the compounds of the liposomes were studied via Fourier-
transform infrared (FT-IR) spectroscopy measurements. 
 
Results and discussion 
Liposome samples with size under 200 nm and polydispersity index lower than 0.30 proving 
homogeneity were prepared while the zeta potential values were slightly negative. The 
particular TG and DSC curves showed that the weight of the samples does not change above 
250°C. Alternations between the formulations prepared with different phospholipid 
combinations were detected. The measured spectra were identical in case of the samples 
prepared from compositions with the same ratios but different PEGylated phospholipids. The 
traces of the FT-IR curves were consistent. 
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The results showed that the usage of 60:40 phospholipid-cholesterol weight ratios led to more 
stable formulations than that of the 80:20. The properties of the liposomes made with ethanol 
96% were better than samples prepared with the chloroform-methanol mixture. The higher ionic 
strength of the hydration media maintained more negative zeta potential. Liposomes made from 
formulations prepared with trehalose as cryoprotectant were smaller than those with inulin; 
however, the inulin-containing formulations were less polydisperse. Samples containing 




It has been shown that the usage of different PEGylated phospholipid compositions influences 
the quality of the liposomes and that those factors should be considered when the formulation 
is optimised. The results of the study set examples for analytical monitoring during the decision-
making process of a liposomal development procedure. 
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